# A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures

> **NCT00545012** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 4 (actual)

## Conditions studied

- Absence Seizures

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00545012
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2003-05
- **Final completion:** 2003-05
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545012, "A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00545012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*